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Editorial
The modern pharmacognosy and the ethnopharmacological 
approach on natural products research
This second issue of the “new” RBFAR - Revista Brasileira de 
Farmacognosia/Brazilian Journal of Pharmacognosy celebrates 
a subject that is one of the axes of modern Pharmacognosy: the 
ethnopharmacology approach on natural products research. 
Ethnopharmacology was once cited as “the oldest modern 
science” (J. Ethnopharmacol, 1984, 11(1):1-16). Nevertheless, 
there is still much to be studied in terms of popular knowledge 
or traditional knowledge associated with natural products. 
Plants, animals, animal products, algae, fungi, microorganisms 
or minerals are often employed with therapeutic purposes 
in many places of the world, by urban and rural societies. In 
this sense, ethnopharmacology can be an important tool in 
the recovery of the millennial and secular knowledge, and 
even contemporary, natural therapeutic resources; allowing 
to combine empirical knowledge and scientific knowledge, 
seeking to apply methods that can demonstrate efficacy and 
safety. So, ethnopharmacology can facilitate the discovery of 
new biologically active agents by reducing the time and cost 
of pharmacological and toxicological screening. Additionally, 
through the implementation of international agreements, 
such as the Convention on Biological Diversity and the Nagoya 
Protocol, this science can still contribute to share benefits 
between bioprospectors and the providers of genetic resources 
and associated traditional knowledge. Accordingly, further 
studies should be stimulated and encouraged in the field of 
ethnopharmacology. However, it is important to discuss the 
advances, advantages and limitations, as well as the problems 
identified in this contemporary science and its publications. 
In recent decades numerous articles on ethnobotany/
ethnopharmacology have been published around the world 
with different approaches and methodologies, many of them 
possibly trying to transform "the old science into a new science". 
But the respect and recognition of ethnopharmacology as a 
discipline depends on the quality and methodological rigor in 
the research and the publications regarding the selection and 
sampling criteria; by the methods employed in field work as 
well as the registration and documentation of data; the coherent 
application of qualitative and/or quantitative approaches, 
among others.
The purpose of this issue was to bring up-to-date knowledge 
of  ethnopharmacology research in Brazil and abroad. The 
contributions received after the call for papers went through 
the RBFAR regular peer review process and followed the same 
norms and processes. Following the review, seventeen papers 
from different Universities of Argentina (1), Brazil (11), Hungary 
(1), Ireland (1), Italy (1), Mexico (1), and UK (1) were accepted for 
publication, covering several aspects of ethnopharmacology. A 
very interesting commentary on the challenges for the future of 
ethnopharmacology  by Dr. Michael Heinrich opens the issue, 
followed by two articles from the group of Dr. Albuquerque 
concerning methodology in ethnopharmacological studies in 
Brazil (sampling problems) and the usefulness of this science 
in drug discovery.  In the following articles, Dr. Monteiro et al. 
discuss the presence of tannins and their relationship with 
medicinal plants choice, and Dr. Coutinho and coworkers 
present the results from their group on the ethnopharmacology 
of a tannin-rich plant in the northeastern region of Brazil. 
From Italy, Dr. Nicoletti and coworkers contributed with 
a nice historical review on the use of Henna and propose a 
quick HPTLC analysis to check its identity. From Hungary 
and Mexico, Dr. Papp and Dr. Solano along with colleagues 
present, respectively, works documenting ethnomedicine 
in Transylvania; and medicinal uses of an Orchidaceae in a 
Mixtec community.  From Brazil, three works from Dr. Silva, 
Dr. Almeida and Dr. Rattes and coworkers documented the 
knowledge and plant uses from communities in the States of 
Minas Gerais, Bahia and Rio Grande do Sul, respectively. From 
Ireland, Dr. Coady and Dr. Boylan contributed with a review 
on the medicinal plants traditionally used in that country.  A 
subsequent article from Dr. Oliveira and coworkers describes 
the pharmacological properties of Lippia origanoides supported 
by previous ethnopharmacological surveys, and work from Dr. 
Nascimento and colleagues describes the plants traditionally 
used in Brazil for Giardiasis treatment. Last but not least, the 
final three articles review, respectively, the botanical diversity 
and toxicological potential of plants sold in open-air markets 
in the state of Rio de Janeiro, Brazil by Leitão and coworkers; 
the safety of medicinal herbs traditionally used in Brazil, by 
Moreira et al.; and the commercialization of medicinal herbs 
in Buenos Aires, Argentina, by Bach and coworkers.
This RBFAR special issue provided an opportunity for 
publication of original, peer-reviewed, full-length articles on 
new research on ethnopharmacology; and we hope that this 
will serve to stimulate the studies in this area. 
http://dx.doi.org/10.1016/j.bjp.2014.05.001
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The Guest Editors would like to thank the contributors 
who gave their time and experience so generously and who 
made this publication a valuable tool for scientists in the field 
of ethnopharmacology. Thanks are also due to the referees 
for their valuable comments and for the very detailed and 
accurate review of manuscripts; their comments certainly 
helped improve the papers. We are also very grateful to 
Prof. Cid Santos, Editor-in-chief of Revista Brasileira de 
Farmacognosia - Brazilian Journal of Pharmacognosy for 
embracing this project with interest and enthusiasm, and for 
the opportunity to publish this special issue. 
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